Genetic variability in susceptibility and response to toxicants
- 31 March 2001
- journal article
- review article
- Published by Elsevier in Toxicology Letters
- Vol. 120 (1-3) , 259-268
- https://doi.org/10.1016/s0378-4274(01)00278-8
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Adverse drug reactions as a cause of admission to an acute medical assessment unit: a pilot studyJournal of Clinical Pharmacy & Therapeutics, 2000
- The Decreased in Vivo Clearance of CYP2D6 Substrates by CYP2D6*10 Might Be Caused Not Only by the Low-Expression but Also by Low Affinity of CYP2D6Archives of Biochemistry and Biophysics, 2000
- Cloning and Initial Characterization of the Human DPYD Gene PromoterBiochemical and Biophysical Research Communications, 2000
- CYP1A1 polymorphisms and lung cancer risk: a meta-analysisPharmacogenetics, 2000
- Disposition of debrisoquine in Caucasians with different CYP2D6-genotypes including those with multiple genesPharmacogenetics and Genomics, 1999
- Acetone catabolism by cytochrome P450 2E1: studies with CYP2E1-null miceBiochemical Pharmacology, 1999
- Cytochrome P450 CYP1B1 determines susceptibility to 7,12-dimethylbenz[ a ]anthracene-induced lymphomasProceedings of the National Academy of Sciences, 1999
- Increased skin tumorigenesis in mice lacking pi class glutathione S -transferasesProceedings of the National Academy of Sciences, 1998
- 10-hydroxylation of nortriptyline in white persons with 0, 1, 2, 3, and 13 functional CYP2D6 genes*Clinical Pharmacology & Therapeutics, 1998
- Drug-Related Hospital AdmissionsAnnals of Pharmacotherapy, 1993